LifeProNow

APRIL 6, 2023

Ethical considerations in HEOR include ensuring that the research is conducted with the highest standards of ethical conduct, respecting the privacy and autonomy of study participants, and ensuring that the results of the research are disseminated in a transparent and unbiased manner.

Drug Development 130

Drug Development 130

Pharmaceutical Technology

MARCH 10, 2023

In a statement released along with the centre’s launch, Steve Barclay, the UK’s Health and Social Care Secretary said, “The investment in this new centre will continue to develop this area of research and help provide patients the best possible care”.

Communication 105

Communication 105

pharmaphorum

MAY 25, 2022

Where it is impossible to restrict access to HCPs, due to the congress platform or equivalent, there must be a clear statement to the attendee that the materials/communication are designed and intended for HCPs only.”. Here, we take a look at the top five takeaways from the document: 1. medical society) of the international congress.

Documentation 104

Documentation Communication Pharmaceutical Manufacturing Labelling 104

Pharmaceutical Technology

MAY 12, 2023

Matinas announced the news in a May 10 statement. Ugur Sahin, CEO and co-founder of BioNTech, said the platform demonstrated encouraging capabilities for oral delivery, in a statement at the time. BioNTech has ended its research collaboration with Matinas after its oral mRNA vaccine failed to demonstrate preclinical activity.

Vaccines 52

Vaccines 52

Pharmaceutical Technology

JUNE 13, 2023

By Cytiva Thematic By downloading this case study, you acknowledge that GlobalData may share your information with Cytiva Thematic and that your personal data will be used as described in their Privacy Policy GlobalData is the parent company of Pharmaceutical Technology.

98

98

FDA Law Blog: Biosimilars

MAY 7, 2023

Palmer — On May 3, 2023, DEA’s Administrator Anne Milgram issued a very brief and lightly publicized statement announcing that DEA intends to issue a “temporary rule” extending telemedicine flexibilities that existed during the COVID-19 Emergency Declaration, which Declaration is set to expire on May 11, 2023. By Karla L.

Controlled Substances 52

Controlled Substances 52

Pharmaceutical Technology

APRIL 3, 2023

The development pipeline of such therapies has been growing strongly and more and more are reaching major milestones,” said René Fáber, member of the executive board and head of the bioprocess solutions division of Sartorius, in a statement.

98

98

Pharmaceutical Technology

MAY 22, 2023

In an August 2022 statement , Moderna stated its technology contained within patents filed between 2010 and 2016 was copied without permission. CureVac’s lawsuits add to a complex legal landscape for Pfizer/BioNTech that already includes ones from Moderna. Pfizer/BioNTech then countersued in December 2022.

Vaccines 116

Vaccines Communication 116

ComputerTalk

OCTOBER 31, 2016

Vendors’ privacy policies can put physicians using speech recognition in a tough spot.

40

40

pharmaphorum

DECEMBER 29, 2022

I support the initiative of simplifying data privacy and the idea of making it more accessible, yet, there are some real challenges the Bill poses for organisations wishing to act from beyond the realms of the UK. However, in practice there are some fundamental issues with what is being proposed in the Bill.

97

97

pharmaphorum

JUNE 8, 2021

The UK’s decision to set back the start date of a new patient data-sharing scheme by two months has been welcomed by privacy campaigners, who have claimed it was being rushed through without sufficient public scrutiny.

Medical Records 98

Medical Records Communication Pharmaceutical Companies Pharmaceutical Companies 98

Putting Patients First Blog

MARCH 25, 2024

Concerns over transportation, mobility, condition type, geography, and privacy could all change a patient’s preference. Rutta Chief Executive Officer [1] NHC-Telemedicine-Briefing-one-pager.pdf (nationalhealthcouncil.org) The post NHC Statement on House Ways and Means Telehealth Hearing appeared first on National Health Council.

Communication 40

Communication Hospitals 40

Putting Patients First Blog

MARCH 25, 2024

Concerns over transportation, mobility, condition type, geography, and privacy could all change a patient’s preference. Rutta Chief Executive Officer [1] NHC-Telemedicine-Briefing-one-pager.pdf (nationalhealthcouncil.org) The post NHC Statement on House Ways and Means Telehealth Hearing appeared first on National Health Council.

Communication 40

Communication Hospitals 40

Pharmaceutical Technology

JUNE 2, 2023

Broader coverage will begin on the day of the drug’s traditional approval, when it comes through, and CMS’ proposed method will aim to collect more real-world evidence on the drug’s use, as per the 1 June statement. upon its widespread use. Clinical investigators commonly use registries to gather information on patient outcomes.

Communication 52

Communication Hospitals 52

Pharmaceutical Technology

APRIL 21, 2023

Emergent Biosolutions, maker of the opioid overdose reversing nasal spray Narcan, intends to price the treatment at less than $50 for a kit of two 4mg doses for over-the-counter use (OTC) the company said in a statement. While justifying the price, the Emergent statement said the company needs to “foster a sustainable business model”.

Packaging 52

Packaging Communication 52

Putting Patients First Blog

APRIL 10, 2024

Concerns over transportation, mobility, condition type, geography, and privacy could all change a patient’s preference. Rutta Chief Executive Officer [1] NHC-Telemedicine-Briefing-one-pager.pdf (nationalhealthcouncil.org) The post NHC Statement for House Energy and Commerce Hearing appeared first on National Health Council.

Packaging 40

Packaging Communication 40

Pharmaceutical Technology

MAY 10, 2023

The British charitable organisation, the Migraine Trust released a statement welcoming the SMC’s decision. Furthermore, a statement from the charity said the drug may help those with contraindications or an inadequate response to the standard of care for migraine treatment—triptans. Vydura is also sold under the brand name Nurtec.

Communication 52

Communication 52

Pharmaceutical Technology

JUNE 20, 2023

F2G claimed in a June statement that the FDA requested additional data and analysis that extended beyond the current review period. The company was seeking approval for Olorofim, an investigational antifungal intended to treat invasive fungal infections in patients with limited treatment options.

Packaging 52

Packaging Labelling Communication 52

Pharmaceutical Technology

JUNE 1, 2023

A statement from the company highlighted frexalimab’s mechanism of action of blocking the CD40/CD40L costimulatory pathway, as one that potentially regulates both adaptive and innate immune cell activation and function, which is pivotal in the pathogenesis of MS.

Labelling 64

Labelling Communication Immunity Immunization 64

Pharmaceutical Technology

JUNE 20, 2023

In a 20 June statement , he said the deal would “[enhance] our efforts to make life better for people living with devastating autoimmune diseases”. At $48 a share for the South San Francisco,California-based biopharma, Lilly is paying a 40% premium on top of the 30-day average trading price.

Communication 52

Communication 52

Pharmaceutical Technology

JUNE 19, 2023

In a June statement, Rosemont CEO Howard Taylor highlighted Lucis’ product pipelines and developer relationships as a driver of the acquisition, accelerating Rosemont’s entry into the sachet market.

Nursing Homes 52

Nursing Homes Communication 52

Pharmaceutical Technology

JUNE 15, 2023

In a 15 June statement, Sandoz said that it hoped the Act4Biosimilars action plan will provide actionable solutions to overcome barriers preventing patient access to biosimilars. Generic and biosimilar pharmaceutical company and Novartis subsidiary Sandoz announced its plan to accelerate patient access to biosimilars.

Biosimilars 52

Biosimilars Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MAY 31, 2023

In its statement, the FDA cited research that says medication nonadherence can cause almost 25% of hospital admissions, 50% of treatment failures, and approximately 125,000 US deaths annually.

Documentation 52

Documentation Communication Hospitals 52

Pharmaceutical Technology

MAY 5, 2023

Previously, ABPI released a statement expressing concerns that the current voluntary scheme may not be fit for purpose in a post-pandemic environment. The two schemes are designed to be complementary and make up total medicine costs by requiring pharmaceutical companies to make clawback payments.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

PharmaState Academy

OCTOBER 20, 2023

a) Observational Research Guidelines b) CONSORT Statement c) Clinical Trial Protocols d) Fictional Case Reports 5 / 20 Which statistical method is commonly used to reduce bias in Real World Evidence studies by matching treated and untreated patients based on their observed characteristics?

Drug Pricing 104

Drug Pricing 104

Pharmaceutical Technology

MAY 9, 2023

In a statement released after the CMS’s initial decision to not cover Alzheimer’s Association statement, the non-profit organisation said, “For CMS to treat those with Alzheimer’s differently than those with other diseases is unprecedented and unacceptable.”

Communication 52

Communication Immunity Immunization 52

Pharmaceutical Technology

MAY 9, 2023

In a statement released after the CMS’s initial decision to not cover Alzheimer’s Association statement, the non-profit organisation said, “For CMS to treat those with Alzheimer’s differently than those with other diseases is unprecedented and unacceptable.”

Communication 52

Communication Immunity Immunization 52

pharmaphorum

DECEMBER 15, 2022

They are experts at providing clear and concise scientific communication through the virtual medium, all while having the professional credentials and credibility to back up their statements. During conferences and congresses, you’ll typically find DOLs live-Tweeting about the different sessions, abstracts, and posters. Connecting peers.

Communication 92

Communication Vaccines 92

Pharmaceutical Technology

MAY 18, 2023

The DeTAP trial clearly demonstrates how using digital technology can increase and speed up clinical trial recruitment while also keeping the participant fully engaged.

Hospitals 52

Hospitals Communication 52

Ramblings of a pharmacist

FEBRUARY 18, 2022

The goal here for me isn’t to make a political statement that the Biden Administration cares about little pharmacies, it’s to restructure the market from the insanity we’re in to a market that is fair to all comers. He has dedicated his career to ensuring the privacy rights of immigrants and working people.

Grocery Stores 40

Grocery Stores Specialty Pharmacies Drug Pricing Documentation 40

Pharmaceutical Technology

DECEMBER 22, 2022

JCA reports will not give statements that may imply and predetermine national reimbursement decisions and will not have a legally binding effect, meaning national HTA bodies are welcome to draw their own conclusions on the clinical added value of the new medicine.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Communication 52